Should Johnson & Johnson Be Getting More Out of Q3 Earnings?
Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday......»»
Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street"s Most Accurate Analysts
Johnson & Johnson (NYSE: JNJ) is set to release earnings results for its first quarter before the opening bell on April 16, 2024. Latest Ratings for J.....»»
J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play
Johnson & Johnson's Q1 earnings report on April 16 is expected to show $2.64 EPS and $21.4 billion in revenues. Technical analysis shows a bearish trend but analysts have a neutral rating with a $171.95 price target and potential 37.15% upside. read more.....»»
Johnson & Johnson Rises on 1st-Quarter Earnings Beat
Company reports solid Covid-19 vaccine sales despite blood clot issuesRelated Stocks: JNJ,.....»»
Stocks slip as traders digest Johnson & Johnson, IBM earnings, $30B Kansas City Southern deal
U.S. equity markets were lower Tuesday as investors assessed a mega-deal in the rail industry and sifted through a slew of earnings reports......»»
U.S. stocks slip, J&J, Kansas City Southern in focus
Dow members – healthcare giants Johnson & Johnson and Procter & Gamble, and property and casualty insurer Travelers top the earnings docket......»»
Netflix, Johnson & Johnson earnings top week ahead
Investors brace for a slew of earnings from Coca-Cola, Johnson & Johnson, United Airlines, Netflix, Chipotle, Intel, Snap, American Express and others in the coming week......»»
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector re.....»»
Earnings Outlook: Here’s how the ‘pause’ on J&J’s COVID-19 shot may or may not affect the company’s earnings
To what degree will Johnson & Johnson’s COVID-19 vaccine manufacturing issues and the federal 'pause' over safety concerns weigh on investors' mind when the company reports earnings next week?.....»»
Earnings Previews: Johnson & Johnson, Lockheed, Philip Morris, Procter & Gamble
Earnings season hits its stride next week and here are previews of four companies reporting March quarter results early Tuesday......»»
: Airline stocks stumble after vaccine rollout snag
U.S. airline stocks fall after Johnson & Johnson’s COVID-19 vaccine is halted with investors keeping an eye on upcoming airline earnings and the uptick in air-travel demand ahead of summer......»»
Recap: Johnson Outdoors Q1 Earnings
Shares of Johnson Outdoors (NASDAQ: JOUT) rose 0.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 206.25% over the past year to $1.96, which beat the estimate read more.....»»
J&J beats earnings estimates in Q4, driven by a 16% jump in sales of Remicade
Shares of Johnson & Johnson were up 0.5% in premarket trading on Tuesday after the company had higher-than-expected sales in the fourth quarter, d.....»»
Johnson Outdoors: Q2 Earnings Insights
Shares of Johnson Outdoors (NASDAQ:JOUT) were unchanged at $62.20 after the company reported Q2 results. Quarterly Results Earnings per share decreased 7.34% over the past year to $2.02, which beat the estimate of $1.60. read more.....»»
Johnson & Johnson Earnings: JNJ Stock Jumps 5% on Strong Q1
InvestorPlace - Stock Market News, Stock Advice & Trading Tips J.....»»
J&J gets a boost from a possible covid-19 vaccine
In an intra date note to investors Gorilla Trades strategist Ken Berman, while commenting on Johnson & Johnson’s earnings and the production of a future... The post J&J gets a boost from a p.....»»
Johnson & Johnson"s 1st-Quarter Earnings and Revenue Edge Past Projections
Company hiked its quarterly dividend to $1.01 per shareRelated Stocks: JNJ,.....»»
Johnson & Johnson"s Earnings and Revenue Edge Past Projections
Company hiked its quarterly dividend to $1.01 per shareRelated Stocks: JNJ,.....»»
Tylenol, Zyrtec sales boost J&J"s profit
The coronavirus crisis drove Johnson & Johnson's quarterly profit higher as consumers stocked up on its over-the-counter drugs. But as Fred Katayama reports, the drug maker lowered its full-year earnings forecast......»»
Wall Street jumps 2% on hopes of lockdown easing; JPMorgan kicks off earnings
Wall Street rose more than 2% on Tuesday on signs some economies would ease strict coronavirus-induced lockdowns, with investors also looking at quarterly earnings from JPMorgan and Johnson & Johnson for clues on the business hit from the outbreak......»»
Wall Street gains as banks, J&J kick off earnings
U.S. stock markets opened more than 1% higher on Tuesday as the quarterly earnings season kicked off with JPMorgan and Johnson & Johnson giving a first glimpse of the coronavirus outbreak's impact on corporate America......»»